Eplerenone Treatment for Chronic Central Serous Chorioretinopathy in Hungarian Population

Phase 4 Completed 28 enrolled Semmelweis University

NaSingle-groupOpen-labelTreatment

Summary

The aim of the study is to determine the efficacy and safety of treatment with the drug eplerenone in patients with chronic central serous chorioretinopathy.

Timeline

Start: 2014-06
Primary completion: 2016-09
Completion: 2016-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Eplerenone	Unknown	50 mg	—

Eplerenone Treatment for Chronic Central Serous Chorioretinopathy in Hungarian Population

Summary

Timeline

Drugs

Indications